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Trypanosoma cruzi, the etiological agent of 
Chagas’ disease, has the ability to respond to a 
variety of environmental changes during its life 
cycle both in the insect vector and in the 
vertebrate host. Since regulation of 
transcription initiation seems to be 
nonfunctional in this parasite, it is important to 
investigate other regulatory mechanisms of 
adaptation. Regulatory mechanisms at the level 
of signal transduction pathways involving 
phosphoinositides are good candidates for this 
purpose. Here we report the identification of 
the first phosphatidylinositol 3-kinase (PI3K) in 
T. cruzi, with similarity with its yeast 
counterpart, Vps34p. TcVps34 specifically 
phosphorylates phosphatidylinositol to produce 
phosphatidylinositol 3-phosphate, thus 
confirming that it belongs to class III PI3K 
family. Overexpression of TcVps34 resulted in 
morphological and functional alterations 
related to vesicular trafficking. While inhibition 
of TcVps34 with specific PI3K inhibitors, such 
as wortmannin and LY294,000, resulted in 
reduced regulatory volume decrease after 
hyposmotic stress, cells overexpressing this 
enzyme were resistant to these inhibitors. 
Furthermore, these cells were able to recover 
their original volume faster than wild type cells 
when they were submitted to severe hyposmotic 
stress. In addition, in TcVps34-overexpressing 
cells the activities of vacuolar-H+-ATPase and 
vacuolar H+-pyrophosphatase were altered, 
suggesting defects in the acidification of 
intracellular compartments. Furthermore, 
receptor-mediated endocytosis was partially 
blocked whereas fluid phase endocytosis was 
not affected, confirming a function for TcVps34 
in membrane trafficking. Taken together, these 
results strongly support that TcVps34 plays a 
prominent role in vital processes for T. cruzi 
survival such as osmoregulation, acidification 
and vesicular trafficking. 
 
Phosphatidylinositol 3-kinase (PI3K) activities 
have been found in all eukaryotic cell types 
examined up to date (1,2) and are linked to a 
diverse set of key cellular functions, including cell 
growth, proliferation, survival, and intracellular 
trafficking. PI3Ks belong to a large family of 
enzymes that has been divided into three 
functional classes on the basis of their protein 
domain structure, lipid substrate specificity, and 
regulatory properties. Class I PI3Ks were the first 
ones to be identified and are important 
components of the signaling pathways that 
regulate eukaryotic cell growth (3,4). These PI3Ks 
have a 110-kDa catalytic subunit that exhibits a 
substrate preference for PI 4-phosphate and PI 4,5-
bisphosphate (5). Class II PI3Ks are less well 
known but may also function in the regulation of 
cell growth (5,6), and, additionally, in clathrin-
mediated endocytosis (7,8). These enzymes prefer 
phosphatidylinositol (PI) as substrate but may also 
utilize PI 4-phosphate. Finally, Class III family of 
PI3Ks is related to the yeast vacuolar protein 
sorting 34, Vps34p, and their homologs from other 
eukaryotes. Vps34p-like kinases specifically 
phosphorylate PI to produce phosphatidylinositol 
3-phosphate (PI 3-P) and are associated with a 
Vps15p-like protein kinase (6,9). In addition to 
protein sorting to the vacuole/lysosome, class III 
PI3Ks have been implicated in several other 
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membrane transport events, including endocytosis, 
vesicle acidification and autophagy (10-14).  
The protozoan parasite Trypanosoma cruzi is 
the causative agent of Chagas disease in Latin 
America and the main cause of cardiac death in 
endemic areas. Currently over 15 million people 
are infected and other 28 million people are at risk 
of infection (15). As T. cruzi passes through its 
digenetic life cycle, it encounters extreme 
fluctuations in external osmolarity. These osmotic 
fluctuations occur both within the insect gut (16) 
and also when the parasite moves through the 
vertebrate host. Previous studies on the response 
of T. cruzi to hyposmotic stress have shown that 
both insect and vertebrate stages possess a robust 
regulatory volume decrease (RVD) mechanism 
that completely reverses cell swelling (17). This 
process is accomplished by the efflux of various 
ions and osmolytes (18) and the release of water 
by the contractile vacuole complex (19). In 
addition, it has been found that cyclic AMP levels 
increase when T. cruzi epimastigotes are subjected 
to hyposmotic stress (20). Recently, we described 
a membrane-associated cAMP-specific 
phosphodiesterase, TcrPDEC2, which is inhibited 
by the same inhibitors  that affect the RVD of the 
parasites after hyposmotic stress (20,21). 
TcrPDEC2 is characterized by the presence of a 
FYVE domain, which is a phosphoinositide-
binding motif. It is known that phosphoinositides 
serve as lipid signals required for membrane 
recruitment of several proteins implicated in the 
regulation of vesicular transport and intracellular 
protein sorting (22,23), and control the 
translocation and activity of proteins that contain 
phosphoinositide-binding motifs such as the 
FYVE domain, as well as the pleckstrin 
homology, PX and ENTH domains (23,24). 
Since inhibitors of TcrPDEC2 affect 
osmoregulation in T. cruzi, and TcrPDEC2 
possesses a FYVE domain able to bind to PI 3-P, 
we hypothesized that PI 3-P production might 
have a role in osmoregulation. However, very little 
is known about the phosphoinositide signaling in 
trypanosomatids, and up to now only one 
trypanosome ortholog of Vps34, named TbVps34, 
has been described in Trypanosoma brucei (25). 
However, no functional analysis of this enzyme 
was performed and it is not known whether that 
enzyme specifically catalyzes PI 3-P production 
(25). Here we report the identification and 
functional characterization of TcVps34, the first 
class III PI3K reported in T. cruzi. This study 
provides new insights into the physiological 
importance of the PI3K pathway and describes the 
role of TcVps34 in vital processes, such as 
osmoregulation, acidification, and receptor-
mediated endocytosis. 
 
EXPERIMENTAL PROCEDURES 
 
Chemicals and Reagents- All radiochemicals 
used in this work were purchased from Dupont 
NEN Life Science Products Inc., Boston, MA and 
restriction endonucleases were from New England 
Biolabs Inc., Beverly, MA. Bacto-tryptose, yeast 
nitrogen base and liver infusion were from Difco 
Laboratories, Detroit, MI. All other reagents were 
purchased from Sigma Chemical Co., St. Louis, 
MO. 
Cell Cultures and Extracts- T. cruzi 
epimastigote forms (CL Brener strain) were 
cultured at 28°C for 7 days in LIT medium [5 g.l-1 
liver infusion, 5 g.l-1 bacto-tryptose, 68 mM NaCl, 
5.3 mM KCl, 22 mM Na2PO4, 0.2% (W/V) 
glucose, 0.002% (W/V) hemin] supplemented with 
10% (V/V) newborn calf serum, 100,000 units.l-1 
penicillin and 100 mg.l-1 streptomycin. Cell 
viability was assessed by direct microscopic 
examination. 
For T. cruzi extracts, 108 epimastigotes were 
harvested by centrifugation at 1,500 xg for 10 min 
and washed two times with phosphate-buffered 
saline (PBS). Cell pellets were then resuspended in 
lysis buffer (50 mM HEPES buffer, pH 7.3, 
containing 0.01 mg.ml-1 leupeptin, 25 U.ml-1 
aprotinin, 0.5 mM phenylmethylsulfonyl fluoride 
and 14 mM 2-mercaptoethanol), and lysed by six 
cycles of freezing in liquid N2 and thawing at 4°C. 
The total extracts were further centrifuged for 1 h 
at 100,000 xg to obtain P100 and S100 fractions. 
The Saccharomyces cerevisiae strain, 
SEY6210Δvps34::TRP1 was a kind gift of Dr. 
Yoshinori Ohsumi (26). Before transformation, 
this strain was grown at 30°C in synthetic selected 
media without TRP (Tryptophan), (0.17% (W/V) 
yeast nitrogen base without amino acids and 
ammonium sulphate, 0.5% (W/V) ammonium 
sulphate and 2% (W/V) glucose, supplemented 
with the corresponding amino acid mixture. 
Transformant cells were selected in minimal 
medium without TRP and URA (Uracil). 
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Cloning of TcVps34 Gene- The gene sequence 
corresponding to the T. brucei TbVps34 PI3K 
(AC159405) was used to screen T. cruzi sequences 
in the GeneDB database using the WU-Blast2 
algorithm. Two oligonucleotides carrying hemi-
restriction sites (PI3K-Fw-pENTR-KpnI 5´ 
GGTACCATGGCCACCAACGAAGGCAACGT 
3´ and PI3K-Rv-pENTR-XhoI 5´ 
CTCGAGTTAGTGCCGTGTTGCCTGCGCT 3´) 
were designed from the identified sequence 
(Tc00.1047053511903.160). PCR amplifications 
were carried out using 600-800 ng of T. cruzi 
genomic DNA, 100 ng of each primer, 2.5 mM 
MgCl2, 0.2 mM dNTPs and 2 units of Pfu Ultra 
High-Fidelity DNA polymerase (Stratagene, La 
Jolla, CA). Three PCR products were sequenced 
and compared with the original sequence found at 
GeneDB. Taken into account that some 
discrepancies were detected, we reported the 
obtained sequence to NCBI databank 
(EU276115)4. 
Sequence Analysis- The search in a T. cruzi 
genome database (http://www.genedb.org) was 
performed with Wu-Blast2. Sequence identity was 
analyzed with the BLASTP (URL 
http://www.ncbi.nlm.nih.gov/blast/index.html) and 
Clustal W (URL http://www.ebi.ac.uk/clustalw/). 
Multiple sequence alignment with default 
parameters setting was used to generate the 
alignments. Protein domains were determined 
using SMART (URL http://smart.embl-
heidelberg.de/), and PROSITE (URL 
http://us.expasy.org/prosite/) software. 
Southern, Northern and Western blot 
Analyses- Genomic DNA was purified as 
described by Pereira et al. (27). Total cellular 
RNA was isolated from 108 epimastigote cells in 
the exponential growth phase using TRIzol 
reagents, as described by the manufacturer (Gibco 
BRL., Life Technologies, Rockville, MD) 
Southern and northern blot analyses were 
performed as described by Alonso et al (28). The 
products were revealed with a specific 990-bp 
TcVps34 probe obtained by digestion of the 2,724-
bp fragment with KpnI and PvuII. All probes were 
labelled with α[P32]-dCTP using the Prime-a-Gene 
kit (Promega, Madison, WI) following the 
manufacturer’s instructions. 
For western blot analysis, 80 μg of P100 and 
S100 T. cruzi fractions were loaded into 8% 
(W/V) SDS-polyacrylamide gel electrophoresis as 
described by Laemmli (29) and electrotransferred 
to Hybond-C membranes (Amersham Pharmacia 
Biotech, Piscataway, USA). The transferred 
membranes were then incubated for 4 h with a 
1:2,000 dilution of rabbit anti-6-His (Gene Tex, 
Inc. San Antonio, USA). Detection was carried out 
by incubating with a 1:5,000 dilution of a goat 
anti-rabbit conjugated to peroxidase (KPL Inc., 
Gaithersburg, MA). The latter was developed with 
the ECL PlusTM Western Blotting Detection 
System (NEN Life Science Products Inc., Boston, 
MA). 
Complementation Assay- The coding region of 
TcVps34 gene was excised from the pDEST17 E. 
coli expression vector (Invitrogen, Carlsbad, CA) 
and inserted into the KpnI and XhoI restriction 
sites in the galactose-inducible yeast expression 
vector pYES2 (URA3; Invitrogen). The yeast 
Vps34-knockout strain, SEY6210 Δvps34::TRP1 
was transformed with either the empty vector or 
the vector carrying the TcVps34 gene, using the 
lithium acetate procedure (30). Transformed cells 
were selected in minimal medium (without TRP 
and URA) at 30°C. For complementation assays, 
transformed cells were grown to OD600 = 1.8-2 
with 20% (W/V) glucose as carbon source and 
plated in the same selective media supplemented 
with 20% (W/V) galactose and 10% (W/V) 
raffinose at different dilutions. Plates were 
incubated at 37°C for three days. 
Expression and Purification of Recombinant 
TcVps34 in E. coli- Full-length TcVps34 gene was 
amplified using the following primers carrying 
hemi-restriction sites: (PI3K-Fw-pENTR-KpnI 5´ 
GGTACCATGGCCACCAACGAAGGCAACGT 
3´ and PI3K-Rv-pENTR-XhoI 5´ 
CTCGAGTTAGTGCCGTGTTGCCTGCGCT 3´), 
cloned into pGEM-T Easy plasmid (Promega, 
Madison, WI) and subcloned into the gateway 
pENTR3C vector (Invitrogen). 
To express the N-terminal His-tagged 
TcVps34 in E. coli, a recombination reaction was 
performed to transfer the coding sequence from 
pENTR3C into the pDEST17 expression vector 
(Invitrogen). The construct (pDEST17-TcVps34) 
was transformed into BL21(DE3)pLysS host (E. 
coli B, F-, dem, ompT, hsdS, (rb-, mB-), galλ(DE3), 
[pLysS, camr]) and the recombinant protein was 
induced with 500 μM isopropyl-1-thio-β-D-
galactopyranoside at 30°C for 4 hours. Cells were 
harvested by centrifugation and resuspended in 
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lysis buffer [10 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1 % (V/V) Triton X-100] containing a 
protease inhibitor cocktail (Complete mini, Roche. 
Mannheim, Germany). The protein extract was 
prepared by sonication, centrifuged and 
resuspended in the same lysis buffer. This fraction 
was purified using a Ni-NTA agarose resin 
(Invitrogen) and eluted with lysis buffer 
containing 80 mM imidazole. 
PI 3-kinase Activity Assays and Substrate 
Specificity- PI3K activity assays were carried out 
as described before with some modifications (31). 
Partially purified recombinant protein (rTcVps34, 
0.5 and 5 μg) was assayed in 75 μl reactions 
containing 20 mM Tris-HCl, pH 7.4, 4 mM 
MgCl2, 100 mM NaCl, 2 mg.ml-1 sonicated 
phosphatidylinositol, 40 μM ATP and 25 μCi.ml-1 
γ[32P]-ATP. The mixtures were incubated at 30ºC 
for 15 min and reactions were terminated by the 
addition of 150 μl of 1 M HCl. Lipids were 
extracted first with CHCl3/CH3OH (1:1) plus 10 
mM EDTA and the resulting organic phase was 
then extracted with CH3OH/HCl (100:1) plus 10 
mM EDTA. The obtained organic phase was dried 
with nitrogen gas, resuspended in CHCl3/CH3OH 
(1:1) and spotted onto LK6D silica gel TLC plate 
(Whatman, Philadelphia, PA) pre-treated with 
potassium oxalate and developed with 
CHCl3/CH3OH/NH4OH (40:40:15). Radiolabeled 
phosphoinositides were detected by 
autoradiography. 
For the substrate specificity experiments, the 
PI3K activity assays were carried out as described 
above except that either phosphatidylinositol (PI), 
phosphatidylinositol-4-phosphate (PI 4-P) or 
phosphatidylinositol-4,5-bisphosphate (PI 4,5-P2) 
were included as substrates (2 mg.ml-1).  
For PI3K activity assays using T. cruzi 
epimastigote cell extracts, 25, 50 or 75 μg of total 
protein were used. After a standard activity 
reaction as described above, radiolabeled 
phosphoinositides were measured in a liquid 
scintillation counter and identified by TLC 
followed by autoradiography. Unlabeled PI, PI 4-P 
and PI 4,5-P2 standards were visualized by 
staining with iodine vapors. 
Parasite Transfection- The full-length 
TcVps34 gene was amplified by using the primers 
PI3K-Fw-pTREX-HindIII 5´ 
AAGCTTATGACCACCGAAAACGT 3´ and 
PI3K-Rv-pENTR-XhoI 5´ 
CTCGAGTTAGTGCCGTGTTGCCTGCGCT 3´ 
The TcVps34 gene fused to a His-Tag in the N-
terminal was amplified from the construct 
pDEST17-TcVps34 by using the primer 
pDEST17-Fw-HindIII 
5´AAGCTTATGTCGTACTACCATCACCATCA 
3´ and the same reverse primer PI3K-Rv-pENTR-
XhoI. Both 2,724-bp PCR products were then 
cloned into pGEM-T Easy plasmid and subcloned 
into the pTREX expression vector, which 
integrates in the ribosomal locus and allows high 
expression levels driven by the strong Pol I rRNA 
promoter in T. cruzi (32). 
T. cruzi epimastigotes of CL Brener strain 
were transfected with the pTREX-TcVps34 and 
pTREX-His-TcVps34 constructs as described 
previously (32). Parasites transfected with a 
pTREX-GFP construction were monitored by 
fluorescence microscopy as a selection control. 
Stable cell lines were achieved after 60 days of 
treatment with 500 μg.ml-1 G418 (Gibco BRL, 
Carlsbad, CA) and the transgenic condition was 
confirmed by Southern and western blot analyses. 
Differential Interference Contrast and Video 
Microscopy- Differential interference contrast 
(DIC) and video microscopy images were taken 
using an Olympus IX-71 inverted fluorescence 
microscope with a Photometrix CoolSnapHQ 
CCD camera driven by DeltaVision software 
(Applied Precision, Seattle, WA). For analysis of 
contractile vacuole filling, videomicroscopy of 
epimastigotes adhered to poly-L-lysine-coated 
coverslips and bathed in isosmotic buffer was 
carried out. Videos were recorded for 5 min and 
reconstructed using the DeltaVision Softworx 
software. For videomicroscopy of severe 
hyposmotic treatment, cells were adhered to poly-
L-lysine coated coverslips and bathed in 65 mOsm 
buffer. Videos were recorded for 20 min. 
Electron Microscopy- About 1 × 108 
epimastigote forms were harvested and washed 
twice with PBS. The parasites were fixed with 
freshly prepared 2.5% glutaraldehyde, 4% 
formaldehyde, 0.1 M sodium cacodylate buffer 
(pH 7.3) for 1 h and then embedded in epoxy 
resin, sectioned, and stained using standard 
methods for transmission electron microscopy. 
Images were obtained on a Zeiss 900 transmission 
electron microscope operating at 80 kV. For 
scanning electron microscopy, cells were fixed as 
before, adhered to poly-L-lysine-coated coverslips, 
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dehydrated in ethanol series, critical point dried 
and coated with gold in a Balzers gold sputtering 
system. Cells were observed in a JEOL JSM 
6340F Field Emission Scanning Electron 
Microscope operating at 5 kV. 
Regulatory Volume Decrease- Epimastigotes 
were collected and washed twice with isotonic 
chloride buffer (Iso-Cl buffer, 137 mM NaCl, 4 
mM KCl, 1.5 mM KH2PO4, 8.5 mM Na2PO4, 20 
mM HEPES, 11 mM glucose, 1 mM CaCl2, 0.8 
mM MgSO4, pH 7.4). The osmolarity of the buffer 
was adjusted to 300 ± 5 mOsm as verified by an 
Advanced Instruments 3D3 Osmometer 
(Norwood, MA). The washed cells were 
resuspended in Iso-Cl buffer to a cell density of 1 
x 108.ml-1 cells. The cells were distributed in 96-
well plates with 150 μl per well in triplicate and 
hyposmotic stress was induced by 1:1 dilution of 
cell suspension with sterile deionized water, 
resulting in a final osmolarity of 150 mOsm. The 
absorbance changes at 550 nm were recorded 
every 20 s for 10 min using a SpectraMax M2e 
plate reader (Molecular Devices) (18). 
Membrane Integrity and Amino Acid Release- 
After treatment with the inhibitors wortmannin 
and LY294,000, membrane integrity was 
determined by ethidium bromide exclusion as 
described by Rohloff et al (18). Total amino acid 
analysis of the cell extracts and the supernatant 
fraction of epimastigote cells exposed to hypotonic 
or isotonic buffer were determined as described 
before (18). 
H+ Transport Assays- Active H+ transport was 
assayed as described previously (33), by 
measuring changes in the absorbance of acridine 
orange (493-530 nm) in an OLIS modified SLM-
Aminco DW2000 dual-wavelength 
spectrophotometer. Briefly, for H+-ATPase 
activity, epimastigotes were incubated at 30°C in a 
2.5 ml standard reaction medium containing 125 
mM sucrose, 65 mM KCl, 1 mM MgCl2, 10 mM 
HEPES pH 7.2, 2 mM KH2PO4, 450 μM EGTA, 4 
μM acridine orange (AO) and 1 μM of digitonin. 
At the indicated time the reaction was started by 
adding 1 mM ATP. Bafilomycin A1 and sodium o-
vanadate were added at 1 μM and 100 μM 
respectively. For H+-PPase activity, the standard 
reaction medium contained 130 mM KCl, 10 mM 
HEPES pH 7.2, 2 mM KH2PO4, 450 μM EGTA, 4 
μM acridine orange (AO) and 1 μM of digitonin. 
At the indicated times the reaction was started by 
adding 100 μM PPi and the specific inhibitor 
aminomethylenediphosphonate (AMDP) was 
added at 100 μM. Each experiment was repeated 
at least three times with different cell preparations. 
Transferrin and Fluid Phase Uptake- For 
FITC-transferrin (Molecular Probes, Invitrogen) 
uptake epimastigotes were harvested and washed 
twice in serum-free LIT medium (sfLIT). The cells 
were incubated at 28°C for 10 min in sfLIT. FITC-
transferrin (50 μg.ml-1) was added, and the cells 
were further incubated at 28°C for various periods 
of time. Uptake was stopped by the addition of 
ice-cold sfLIT and the cells were washed once at 
4°C and fixed for 30 min in 4% formaldehyde in 
PBS. The cells were adhered to slides, mounted, 
and examined immediately. 
Fluid phase uptake was monitored with FITC-
BSA (Sigma, Saint Louis, MI). Uptake was 
performed as described above using 50 μg.ml-1 of 
FITC-BSA. 
For fluorescence quantification, the images 
were taken under non-saturating conditions using 
identical exposure times. Fluorescence intensity 
was determined using Data Inspector program of 
the Delta Vision Restoration System. 
 
RESULTS 
 
Cloning and Characterization of the TcVps34 
Gene- A search of T. cruzi databases using the 
TbVps34 gene from T. brucei as query resulted in 
the identification of an orthologous sequence in 
this parasite (Tc00.1047053511903.160). Two 
oligonucleotides designed from this sequence were 
used to amplify the T. cruzi gene using genomic 
DNA as template. After sequencing TcVps34, the 
2,724-bp open reading frame was identified. The 
sequence contained several differences from that 
reported at the GeneDB database and was 
therefore annotated at the NCBI under the 
accession number EU2761154. 
The predicted amino acid sequence of 
TcVps34 presented the phosphoinositide 3-kinase 
class III accessory domain (amino acids 318 – 
477), which has been suggested to be involved in 
substrate presentation, and the phosphoinositide 3-
kinase catalytic domain (amino acids 513 – 906). 
In addition, TcVps34 possesses a C2 domain at the 
N-terminal region (amino acids 97 – 222), which 
is present in several proteins related to signal 
transduction (Supplemental data S1). Amino acid 
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sequence analysis showed that TcVps34 has the 
highest identity (57.4%) with T. brucei Vps34 
(XP_847451), followed by the Leishmania major 
and S. cerevisiae orthologs (35.1% and 25.7%, 
respectively) (Supplemental data S1). In addition, 
TcVps34 presented only 27.5% of identity with 
the human class III PI3K (NP_002638). 
TcVps34 Complements a Yeast Vps34-
Knockout Strain- To analyze whether the TcVps34 
gene encodes a functional PI3K, the TcVps34 
coding region was subcloned into pYES2 
expression vector and used to complement a S. 
cerevisiae Vps34-knockout strain 
(SEY6210Δvps34::TRP1), which possesses a 
temperature-sensitive phenotype. Expression of 
TcVps34 restored the ability of mutant cells to 
grow at 37ºC, whereas transformation with the 
empty vector did not, indicating that the TcVps34 
gene encodes a catalytically active PI3K (Fig. 1). 
TcVps34 is a Functional Class III 
Phosphatidylinositol 3-Kinase- The formation of 
phosphatidylinositol 3-phosphate (PI 3-P) by 
TcVps34 was tested using the partially-affinity 
purified recombinant protein (Fig. 2A). After a 
standard PI3K radioactive assay, phosphorylated 
lipids were resolved by TLC and revealed by 
autoradiography. The recombinant protein was 
able to phosphorylate phosphatidylinositol (PI) 
giving PI 3-P as the major product, as evidenced 
by the position of the standards run in a borate 
buffer system (34). The detection of this product 
was dependent on the protein concentration and 
was very weak in non-induced E. coli extracts 
(Fig. 2B), indicating that endogenous E. coli 
proteins were not responsible for the PI3K 
activity. In addition, the recombinant TcVps34 
substrate specificity was studied using 
phosphatidylinositol (PI), phosphatidylinositol-4-
phosphate (PI 4-P) and phosphatidylinositol-4,5-
bisphosphate (PI 4,5-P2) as substrates. The enzyme 
only phosphorylated PI producing PI 3-P and was 
not able to use either PI 4-P or PI 4,5-P2 as 
substrate (Fig. 2C). These findings, together with 
the sequence data, led us to conclude that 
TcVps34 belongs to the class III PI3K family. 
TcVps34-overexpressing Epimastigotes Show 
a Singular Phenotype- Since Vps34 is essential in 
other trypanosomatids studied (25), we 
investigated the phenotypic changes induced by 
TcVps34 overexpression. A His-tagged version of 
the TcVps34 gene was subcloned into the pTREX 
integration vector (pTREX-His-TcVps34) and 
transfected into CL Brener epimastigote cells. 
Stable cell lines were achieved after 60 days of 
selection in the presence of G418. 
Southern blot analysis indicated that TcVps34 
is a single-copy gene. In addition, the presence of 
an extra copy of TcVps34, integrated into the 
genome of the transfected overexpressing cells, 
was evidenced as an extra hybridization band (Fig. 
3A). TcVps34 expression in the transgenic cells 
was analyzed by northern and western blot, 
showing increased levels for the specific mRNA in 
pTREX-His-TcVps34-transfected parasites when 
compared with wild type CL Brener controls and 
the presence of the tagged protein only in pTREX-
His-TcVps34-transfected cells (Fig. 3B and C). 
Coomassie blue staining showed equivalent 
amounts of protein in the P100 and S100 fractions 
(results not shown). Furthermore, when PI3K 
activity assays were carried out using 25 and 75 
μg of total epimastigote extracts, pTREX-His-
TcVps34-overexpressing cells showed a 2.5-fold 
increase when compared to control cells, thus 
confirming that activity was linearly dependent on 
protein concentration and overexpression of a 
functional enzyme (Fig. 3D). 
Examination of cultures by differential 
interference contrast (DIC) microscopy (Fig. 4A), 
transmission electron microscopy (TEM; Fig. 4B), 
and video microscopy (Fig. 4C and supplemental 
data S2) revealed striking morphological 
differences between pTREX-His-TcVps34-
overexpressing cells and wild type cells. Cells 
overexpressing His-TcVsp34 showed enlarged 
contractile vacuoles when compared to wild type 
cells (Fig. 4A). At the electron microscopy level 
(Fig. 4B), contractile vacuoles were visible in most 
cells overexpressing TcVsp34, whereas this was 
not the case in wild type cells, as also observed by 
DIC (Fig. 4A). To exclude the possibility that the 
histidine tag was playing a role in the observed 
phenotype, transgenic parasites overexpressing the 
full-length TcVps34 gene without the tag were 
generated and their phenotype evaluated as 
described above for pTREX-His-TcVps34. These 
parasites showed the same morphological 
alterations when analyzed by DIC and TEM (Fig. 
4A, right panel and Fig. 4B respectively) 
indicating that these alterations are due to the 
enhanced expression of TcVps34. Moreover, these 
enlarged organelles were functional, as evidenced 
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by following their periodic filling under video 
microscopy, when pTREX-His-TcVps34-
overexpressing epimastigotes were incubated in 
isosmotic buffer (300 mOsm; Fig. 4C and 
supplemental data S2). Furthermore, most 
pTREX-His-TcVps34- and pTREX-TcVps34-
overexpressing cells (approximately 95%) 
displayed a hypertrophic alteration of the plasma 
membrane between the cytostome and the flagellar 
pocket, as detected by scanning electron 
microscopy (SEM, Fig. 5). 
 
Effect of PI 3-kinase Inhibitors on the 
Regulatory Volume Decrease in Control and 
pTREX-His-TcVps34-overexpressing Cells- Due 
to the distinctive phenotype with enlarged 
contractile vacuoles observed in the pTREX-His-
TcVps34-overexpressing cells, a possible role for 
TcVps34 in the adaptation to hyposmotic stress 
was next investigated. Wild type CL Brener and 
pTREX-His-TcVps34-overexpressing 
epimastigotes were pre-incubated for 30 min with 
3 μM wortmannin or 60 μM LY294,000 and then 
subjected to hyposmotic stress. Regulatory volume 
decrease (RVD) was followed by light scattering 
and compared with untreated controls. These 
inhibitors considerably reduced the RVD in wild 
type cells, whereas they had no effect on pTREX-
His-TcVps34-overexpressing parasites (Fig. 6A 
and B). To exclude the possibility of toxic side 
effects due to the treatment with the inhibitors, we 
confirmed that the plasma membrane remained 
intact and that the hyposmotically induced amino 
acid efflux was not affected (data not shown). 
Since overexpression of TcVps34 could be limiting 
the effects of the PI3K inhibitors with other 
possibly present lipid kinases that these inhibitors 
can affect, we investigated the lipid kinase activity 
in wild type and pTREX-His-TcVps34-
overexpressing parasites in the presence of 3 μM 
wortmannin and 60 μM LY294,000. Similarly, we 
observed that both compounds inhibited the lipid 
kinase activity in wild type cells (41 and 30 % 
approximately for wortmannin and LY294,000 
respectively) whereas they had a minor effect in 
pTREX-His-TcVps34-overexpressing parasites (9 
and 5 %  approximately for wortmannin and 
LY294,000 respectively). Videomicroscopy of 
both pTREX-TcVps34- and pTREX-His-TcVps34-
overexpressing epimastigotes submitted to severe 
hyposmotic stress (65 mOsm) showed that, in 
contrast to wild type cells, after 20 min incubation, 
TcVps34-overexpressing cells were able to recover 
their original volume (Fig. 6C, supplemental data 
S3, S4 and S5). Taken together, these results 
suggest an active role for TcVps34 in the parasite 
response to hyposmotic stress. It is important to 
remark that no differences were observed when 
wild type cells were compared with those 
transfected with the pTREX-GFP vector (data not 
shown). 
H+-ATPase and H+-PPase Activities in 
pTREX-His-TcVps34-overexpressing Cells- It has 
been reported that in Candida albicans, Vps34p 
interacts with Vma7p, a subunit of the vacuolar 
H+-ATPase. In addition, C. albicans Vps34-null 
mutants show vacuolar acidification defects, as a 
result of a defective proton transport into the 
vacuole, due to the lack of Vps34p-Vma7p 
interaction (35). In order to investigate the 
influence of TcVps34 in intracellular acidification, 
we studied the H+-ATPase and H+-PPase activities 
in pTREX-His-TcVps34-overexpressing cells. In 
this assay, vesicle acidification induced by ATP or 
pyrophosphate (PPi) was measured as the decrease 
in absorbance of acridine orange at 493-530 nm in 
permeabilized parasites (33). Results showed that 
ATP-dependent proton uptake was higher in 
pTREX-His-TcVps34-overexpressing cells (Fig. 7, 
trace b) than in wild type cells (Fig. 7, trace a). 
This activity was strongly inhibited by 1 μM of 
bafilomycin A1, a specific inhibitor of the 
vacuolar-type H+-ATPases (36) (Fig. 7A), and less 
affected by 100 μM of sodium o-vanadate, an 
inhibitor of P-type H+-ATPases (37) (Fig. 7B). 
This suggests that proton transport by intracellular 
compartments in both wild type and pTREX-His-
TcVps34-overexpressing cells is mainly achieved 
by the vacuolar-type H+-ATPase. Interestingly, in 
contrast to that observed for ATP-driven proton 
uptake, PPi-dependent proton transport was higher 
in wild type cells (Fig. 7C, trace a) than in 
pTREX-His-TcVps34-overexpressing cells (Fig. 
7C, trace b). This transport was strongly inhibited 
by 100 μM of aminomethylenediphosphonate 
(AMDP), a pyrophosphate analog that specifically 
inhibits vacuolar proton pyrophosphatases (38) 
(Fig. 7C). These results indicate that 
overexpression of TcVps34 produces alterations in 
vesicle acidification, and suggest that changes in 
acidification mediated by these two pumps might 
be coordinated. In all experiments, proton gradient 
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was collapsed and intraorganellar pH was 
neutralized with the addition of 1 μM of the K+/H+ 
ionophore nigericin. 
Receptor-Mediated and Fluid Phase 
Endocytosis in pTREX-His-TcVps34-
overexpressing Cells- To study whether TcVps34 
participates in the endocytic pathway, fluid phase 
uptake of BSA and receptor-mediated endocytosis 
of transferrin were analyzed and quantified by 
fluorescence microscopy. Uptake of the fluid 
phase marker FITC-BSA was not affected in 
pTREX-His-TcVps34-overexpressing cells when 
compared with wild type parasites (data not 
shown). However, receptor-mediated endocytosis 
measured with FITC-transferrin was significantly 
blocked in pTREX-His-TcVps34-overexpressing 
cells observed at 10 and 30 min (Fig. 8A and B, 
respectively). Quantification of fluorescence 
indicates an important reduction of internalized 
transferrin in pTREX-His-TcVps34-
overexpressing cells (p < 0.0001) (Table 1). These 
results suggest that TcVps34 is involved mainly in 
the transport of cargo taken up by receptor-
mediated endocytosis to the lysosome, and they 
are in agreement with previous observations 
reported for other lower eukaryotic cells such as T. 
brucei and S. cerevisiae (23,25). 
 
DISCUSSION 
 
Little is known about the response 
mechanisms that allow survival of 
trypanosomatids when subjected to the 
environmental changes that occur throughout their 
life cycles. A very important aspect is their 
capacity to adapt to different osmotic conditions. 
A previous work has demonstrated a relationship 
between the regulatory volume decrease (RVD) 
that occurs after hyposmotic stress and the cAMP 
signaling pathway (20). More recently, we 
characterized a membrane-associated cAMP-
specific phosphodiesterase that possesses a FYVE 
domain, which is known to bind to membranes 
enriched in PI 3-P and whose activity is modulated 
by the same inhibitors that affect RVD during the 
hyposmotic stress (39). These results led us to 
investigate the importance of PI 3-P production in 
the osmoregulation of trypanosomatids. 
In this work, we characterized TcVps34, the 
first Class III PI3K described in T. cruzi, and 
found that this PI3K participates in receptor-
mediated endocytosis and osmoregulation in this 
parasite. TcVps34 is a single-copy gene and shares 
a high degree of similarity with its mammalian, S. 
cerevisiae, and T. brucei orthologs. Moreover, its 
protein sequence conserves the Class III PI3K 
domain structure, with an N-terminal C2 domain, 
an accessory domain, and a C-terminal kinase 
domain. The enzyme is functional as indicated by 
the reversion of the thermosensitive phenotype of 
a S. cerevisiae Vps34-knockout strain. We also 
demonstrated that the recombinant protein 
exclusively phosphorylated PI to produce PI 3-P, 
supporting our analysis that TcVps34 belongs to 
the group of Class III PI3Ks. 
TcVps34 overexpression in epimastigotes 
produced distinctive morphological and functional 
changes related to membrane trafficking. The 
presence of enlarged and functional contractile 
vacuoles was evident in most TcVps34-
overexpressing parasites. In addition, some of 
these cells showed hypertrophic alterations in the 
region near the cytostome and the flagellar pocket. 
This phenotype could be originated by a higher 
membrane trafficking from the enlarged 
contractile vacuole to these sites, where T. cruzi 
exchanges material with the environment (40). 
Furthermore, pre-incubation of non-transfected 
epimastigotes with the PI3K inhibitors 
wortmannin or LY294,000 reduced the regulatory 
volume decrease of the parasites subjected to 
hyposmotic stress. Previous studies have shown 
that the physiological increase in cell volume is a 
potent stimulus for Class I PI3K activation 
(41,42); however, there is little information about 
the activation of Class III PI3Ks under hyposmotic 
stress. Although wortmannin and LY294,000 
inhibit all PI3Ks to some extent, the observation 
that plants (43) possess only one Class III PI3K 
and S. cerevisiae (44) and T. brucei (25) possess 
only one genuine PI3K that appears to be Class III 
by sequence comparison, together with our 
analysis of the T. cruzi genome, supports the idea 
that the observed effects are related to the 
inhibition of TcVps34. We conclude that TcVps34 
has therefore a role in osmoregulation. It is 
interesting to note that Braga et al. (45) have 
reported that epimastigotes of T. cruzi (Y strain) 
treated with wortmannin also show morphological 
alterations in the flagellar pocket and membrane 
detachment from the flagellum. These 
observations might indicate a connection between 
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TcVps34 and membrane trafficking, since the 
flagellar pocket together with the cytostome are 
the main sites where this process takes place in 
trypanosomatids (40,46). Similar observations 
have been made upon knockdown of TbVps34 
expression by RNA interference in T. brucei (25). 
A previous work has demonstrated that 
antibodies against human Vps34 (hVps34) 
interfere with sorting of endocytosed PDGF 
receptors and weakly inhibit transferrin recycling 
(47). Furthermore, the existence of an alternative 
recycling pathway dependent on PI3K activity has 
been reported (48). In this regard, our results 
indicate that fluid phase endocytosis is not 
affected in pTREX-His-TcVps34-overexpressing 
cells, but that, surprisingly, as it occurs after the 
knockdown of TbVps34 in T. brucei, 
overexpression of TcVps34 in T. cruzi produces a 
blockage of receptor-mediated endocytosis. This 
could be due to a possible down-regulation of the 
endocytic pathway, to a defect in recycling of 
surface receptors, or to a dominant negative effect 
of the overexpressed protein. Furthermore, in 
mammalian cells it has been described that PI3K 
activity regulates the sorting of the EGF receptor, 
whereas the transport of fluid phase markers 
remains unaffected (49). 
Recently, the interaction of Vps34p and a 
subunit of the vacuolar-type H+-ATPase has been 
reported in C. albicans (35). In addition, C. 
albicans vps34-null mutants show acidification 
defects (31). Therefore, the functional data 
obtained in this organism resemble the alterations 
observed in pTREX-His-TcVps34-overexpressing 
epimastigotes, although the hypothesis of an 
interaction of TcVps34 and T. cruzi vacuolar-type 
H+-ATPase remains to be investigated. 
Interestingly, the observation that pTREX-His-
TcVps34-overexpressing cells showed higher V-
H+-ATPase and lower H+-PPase activities than 
wild type parasites suggests that both pumps might 
be coordinated in order to regulate the pH levels of 
intracellular compartments. 
It is worth mentioning that in T. cruzi both V-
type H+-ATPase and H+-PPase localize to the 
acidocalcisomes among other cellular locations 
(19,36,38). Acidocalcisomes are acidic calcium-
containing organelles that, together with the 
contractile vacuole, play a very important role in 
osmoregulation in T. cruzi (20). This might 
suggest that the alterations in osmoregulation 
observed in the presence of PI3K inhibitors could 
be linked to the defects in proton uptake in the 
pTREX-His-TcVps34-overexpressing cells. In 
contrast, H+ uptake was poorly affected by 
vanadate, a specific inhibitor of the P-type H+-
ATPase, which is mainly localized in 
reservosomes (50), thus suggesting that this pump 
is scarcely altered by TcVps34 overexpression. 
In summary, the present work provides the 
first evidence for the presence of a Class III PI3K 
in T. cruzi, and describes its role in 
osmoregulation. Our results also suggest a role for 
TcVps34 in protein trafficking and vesicle 
acidification as it occurs with its orthologs in other 
organisms (Fig. 9). The unique features of T. cruzi 
vesicular trafficking lead us to propose that this 
pathway could provide promising targets for the 
chemotherapy of Chagas’ disease. 
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FIGURE 1. Complementation of a yeast Vps34-knockout strain. The temperature-sensitive 
Δvps34::TRP1 strain SEY6210 was transformed with either the pYES2 empty vector (pYES) or with the 
same plasmid carrying the full-length TcVps34 gene (pYES-TcVps34). Several dilutions were plated into 
synthetic selective media (without tryptophan and uracil) and grown for 72 h at 37ºC. 
 
FIGURE 2. Lipid kinase activity of recombinant TcVps34. (A) The His-tagged TcVps34 recombinant 
protein was affinity purified from the soluble fraction of IPTG-induced E. coli BL21(DE3) using a Ni-
NTA agarose resin and samples were examined by SDS-PAGE (Coomassie Blue-stained). Lane 1: non-
induced soluble fraction; lane 2: induced soluble fraction; lane 3: molecular weight marker; lane 4: flow-
through; lane 5: wash; lanes 6, 7, 8 and 9: elutions with 40, 80, 250 and 500 mM imidazole respectively. 
Lane 1 and Lane 2 were loaded with the same amount of protein. (B) The 80 mM elution fraction of the 
His-tagged recombinant TcVps34 was incubated with γ[32P]-ATP and phosphatidylinositol. After 
incubation with the indicated amounts of protein, the reaction products were separated by TLC and 
labeled lipids were detected by autoradiography. The main product, phosphatidylinositol 3-phosphate (PI 
3-P); the migration of standards: phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PI 4-P), 
phosphatidylinositol-4,5-bisphosphate (PI 4,5-P2) and the Origin are identified by arrows. (C) For 
substrate specificity, PI3K assays were performed as above in the presence of phosphatidylinositol (PI), 
phosphatidylinositol-4-phosphate (PI 4-P) and phosphatidylinositol-4,5-bisphosphate (PI 4,5-P2) as 
substrates. Phosphatidylinositol 3-phosphate (PI 3-P); the migration of standards: phosphatidylinositol 
(PI), phosphatidylinositol 4-phosphate (PI 4-P),  phosphatidylinositol-4,5-bisphosphate (PI 4,5-P2) and the 
Origin are identified by arrows. 
 
FIGURE 3. Molecular analysis of pTREX-His-TcVps34-transfected cells. (A) Southern blot analysis 
of wild type and pTREX-His-TcVps34-transfected parasites. Total genomic DNA (5 μg) was digested 
with the restriction enzymes NsiI, BanI, SacII (which cut in the positions 735, 639 and 592 of TcVps34 
respectively) and HindIII (which cuts the position 1041 of the TcVps34 gene); electrophoresed; blotted 
and hybridized with a probe corresponding to the first 990-bp of the TcVps34 coding region. (B) Northern 
blot analysis of wild type and pTREX-His-TcVps34-transfected parasites. Total RNA (30 μg) from wild 
type or pTREX-His-TcVps34-transfected parasites was electrophoresed in agarose-formaldehyde gels, 
blotted and hybridized with the same probe described above. The migration position and loading control 
corresponding to the three ribosomal RNA bands are indicated. (C) Western blot analysis of wild type and 
transfected parasites. Western blot were performed using soluble (S100) or membrane (P100) fractions 
(80 μg) from wild type (WT) or pTREX-His-TcVps34-transfected parasites (His-TcVps34) and the 
recombinant protein (Rec) purified from E. coli (5 μg) as control; resolved by SDS-PAGE (8% gels); 
electrotransferred on to Hybond C membranes and revealed with an anti-6-His antibody. (D) Enhanced 
PI3K activity in pTREX-His-TcVps34-transfected parasites. PI3K activity assays were performed as 
described under Experimental Procedures using 25 and 75 μg of wild type (WT) and pTREX-His-
TcVps34 (His-TcVps34) total parasite extracts. Bars represent the standard deviation of duplicates. 
 
FIGURE 4. Overexpression of TcVps34 in T. cruzi epimastigote cells causes morphological 
alterations. (A) Transgenic wild type, pTREX-His-TcVps34- and pTREX-TcVps34-overexpressing cells 
were adhered to poly-L-lysine coverslips, bathed in isosmotic buffer and examined by differential 
interference contrast microscopy. Arrows show large contractile vacuoles. Note the absence of a large and 
visible vacuole in the wild type cells. (B) Transmission electron microscopy of pTREX-His-TcVps34- and 
pTREX-TcVps34-overexpressing cells (His-TcVps34 and TcVps34 respectively). Arrows show large 
contractile vacuoles and arrowheads show acidocalcisomes containing electron-dense material near the 
contractile vacuole membrane. Flagellar pocket is indicated as FP. (C) Video microscopy of contractile 
vacuole filling and emptying in pTREX-His-TcVps34-overexpressing cells. The cells were treated as in 
“(A)”, video microscopy data were collected, and selected frames are shown. Numbers in each frame 
indicate the time lapse. Arrows show the position of the contractile vacuole. 
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FIGURE 5. TcVps34-overexpressing epimastigotes show morphological alterations in the plasma 
membrane region between the cytostome and the flagellar pocket. Field emission scanning electron 
microscopy revealed swelling of the plasma membrane region between the cytostome and the flagellar 
pocket (arrow) in pTREX-His-TcVps34-overexpressing cells (A) when compared to wild type cells (inset 
in A). The same phenotype was observed in pTREX-TcVps34-overexpressing parasites (non-tagged 
overexpressing cells, panel B). Panel C and D show magnifications of the regions indicated by squares in 
panel B. 
 
FIGURE 6. Effect of PI 3-kinase inhibitors on regulatory volume decrease. Wild type (A) and 
transfected pTREX-His-TcVps34-overexpressing cells (B) were pre-incubated with either 3 μM 
wortmannin (triangles) or 60 μM LY294,000 (squares), and then subjected to hyposmotic stress. Volume 
recovery compared with untreated controls (circles) was followed by light scattering. Results are 
representative of those obtained from at least three independent experiments. (C) Time lapse snapshots of 
wild type (WT) and transfected pTREX-His-TcVps34-overexpressing cells (TcVps34) subjected to 65 
mOsm hyposmotic stress. Note that in contrast to WT cells, pTREX-His-TcVps34-overexpressing cells 
were able to recover their original volume. 
 
FIGURE 7. H+-ATPase and H+-PPase activities. Acridine orange uptake assay conditions were as 
described under Experimental Procedures. (A) trace a, wild type cells, no additions; trace b, pTREX-His-
TcVps34-overexpressing cells, no additions; trace c, wild type cells plus 1 μM bafilomycin A1 (BAF); 
trace d, pTREX-His-TcVps34-overexpressing cells plus 1 μM bafilomycin A1. (B) Trace a, wild type 
cells, no additions; trace b, pTREX-His-TcVps34-overexpressing cells, no additions; trace c, wild type 
cells plus 100 μM sodium o-vanadate (VAN); trace d, pTREX-His-TcVps34-overexpressing cells plus 
100 μM sodium o-vanadate. (C) Trace a, wild type cells, no additions; trace b, pTREX-His-TcVps34-
overexpressing cells, no additions; trace c, wild type cells plus 100 μM AMDP; trace d, pTREX-His-
TcVps34-overexpressing cells plus 100 μM AMDP. In all cases, the pH gradient was collapsed after 
addition of 1 μM nigericin (NIG). Results are representative of those obtained from at least three 
independent experiments with different cell preparations. Addition of the substrates (ATP and PPi) and 
specific inhibitors (BAF, VAN and AMDP) are indicated by arrows. 
 
FIGURE 8. pTREX-His-TcVps34-overexpressing epimastigote cells specifically show reduced 
receptor-mediated endocytosis of FITC-transferrin. Wild type and pTREX-His-TcVps34-
overexpressing cells were incubated for 10 min (A) and 30 min (B) with FITC-transferrin. Cells were 
fixed in 4% formaldehyde, adhered to poly-L-lysine slides and examined immediately by differential 
interference contrast and fluorescence microscopy. Bar: 6.7 μm. 
 
FIGURE 9. Multiple roles for TcVps34. Schematic representation of the pathways in which TcVps34 is 
involved. TcVps34 plays a role in osmoregulation, and on this basis the PI3K inhibitors wortmannin and 
LY294,000 reduce the RVD of epimastigotes subjected to hyposmotic stress, resulting in a less water 
movement outside the cell by the contractile vacuole complex (CV) (I). In addition, TcVps34 is 
implicated in vesicle acidification, as suggested by the changes in the activities of the V-H+-ATPase and 
the V-H+-PPase proton pumps localized in the acidocalcisomes (Ac) after its overexpression (II). Finally, 
TcVps34 is involved in membrane trafficking, which is evidenced by a decrease in receptor-mediated 
endocytosis in cells overexpressing this enzyme (III). 
 
Supplemental data S1. Alignment of the full-length sequences corresponding to TcVps34 (accession 
number ABX71159); phosphatidylinositol 3-kinase, putative from Trypanosoma brucei (accession 
number XP_847451); phosphatidylinositol 3-kinase, putative [Leishmania major] (accession number 
XP_001683719) and phosphatidylinositol 3-kinase [Saccharomyces cerevisiae] (accession number 
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NP_013341). The C2 domain (amino acids 97 – 222), phosphoinositide 3-kinase class III accessory 
domain (amino acids 318 – 477), and phosphoinositide 3-kinase catalytic domain (amino acids 513 – 906) 
are denoted by dotted, dashed and solid lines over the sequences, respectively. The numbers indicated 
above are according to the amino acid positions of the TcVps34. Sequences were aligned using the 
ClustalW program and edited with BOXSHADE (3.33c) software. Amino acids are colored as follows: 
white for different residues, black for identical residues, gray for similar and conserved residues. 
 
Supplemental data S2. Videomicroscopy of contractile vacuole filling and emptying. pTREX-His-
TcVps34-overexpressing parasites were adhered to poly-L-lysine coverslips, bathed in isosmotic (300 
mOsm) buffer and the contractile vacuole filling and emptying cycles recorded. 
 
Supplemental data S3. Response to severe hyposmotic treatment of wild type epimastigote cells. 
Parasites were adhered to poly-L-lisine coverslips, bathed in severe hyposmotic (65 mOsm) buffer and 
videos recorded for 20 min. 
 
Supplemental data S4. Response to severe hyposmotic treatment of pTREX-His-TcVps34-
overexpressing parasites. Cells were adhered to poly-L-lisine coverslips, bathed in severe hyposmotic (65 
mOsm) buffer and videos recorded for 20 min. 
 
Supplemental data S5. Response to severe hyposmotic treatment of pTREX-TcVps34-overexpressing 
parasites. Cells were adhered to poly-L-lisine coverslips, bathed in severe hyposmotic (65 mOsm) buffer 
and videos recorded for 20 min. 
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Table 1. Quantification of receptor-mediated endocytosis of FITC-transferrin. Fluorescence intensity 
of FITC-transferrin uptake was quantified as described under Experimental Procedures. The values 
represent the mean fluorescence (arbitrary units) of at least 60 cells for each condition. 
 
Time 
(min) 
FITC-transferrin fluorescence in 
wild type cells 
FITC-transferrin fluorescence 
in pTREX-His-TcVps34-
overexpressing cells 
% endocytosis 
inhibition 
10 565.20 ± 120.94 242.06 ± 55.85 55.85 
30 658.94 ± 150.93 278.89 ± 63.65 57.67 
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Figure 1 
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Figure 2 
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Figure 3  
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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Figure 9 
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